» GeneSight multi-gene test more predictive of antidepressant response
Retrospective chart review also showed GeneSight results can help predict increased healthcare visits and higher disability claim benefitsThe combinatorial, multi-gene GeneSight test has been...

» NeuroPhage to Participate on Neuroscience Drug Development Panel at MassBio Annual Meeting March 27, 2015

CAMBRIDGE, Mass., March 20, 2015 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., today announced that Jonathan Solomon, CEO, will participate on an expert panel, "Neuroscience Therapeutics Development: Challenges, Opportunities and the Road Ahead," at the Massachusetts...

» Psychedelic drug use 'does not increase risk for mental health problems'
A new study suggests that the stereotype of LSD users developing psychosis is largely a myth, and that the drug may even have some beneficial properties.